Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

10,165 total articles

Natera Executive Executes Stock Sale Following RSU Vesting

Natera Executive Executes Stock Sale Following RSU Vesting

John Fesko, who serves as the President and Chief Business Officer of Natera, Inc. (NASDAQ:NTRA), has completed a sale of company shares totaling $344,516. The transaction, which occurred on April 27, 2026, involved the sale of 1,688 shares of common stock. According to recent SEC filings, these sales were executed under a pre-arranged Rule 10b5-1 …

Natera Executive Executes Share Sales for Tax Obligations

Natera Executive Executes Share Sales for Tax Obligations

Solomon Moshkevich, the President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), completed two transactions involving the sale of 2,182 shares of company common stock on April 27, 2026. The total value of these sales amounted to $445,340, with share prices falling between $203.75 and $204.39. These disposals were executed via pre-arranged w…

Estrella Immunopharma CFO Executes Recent Common Stock Purchases

Estrella Immunopharma CFO Executes Recent Common Stock Purchases

Xu Jiandong, the Chief Financial Officer of Estrella Immunopharma, Inc. (NASDAQ:ESLA), has completed several transactions to acquire additional shares of the company's common stock. These acquisitions, occurring in late 2025, involved both direct and indirect holdings. While these moves represent an increase in insider positioning, the company’s st…